Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Aug 1;24(4):266-273.
doi: 10.1097/ACI.0000000000000996. Epub 2024 May 20.

State of the art: the treatment of systemic lupus erythematosus

Giulia Costanzo  1 , Andrea Giovanni Ledda, Giada Sambugaro
Affiliations
Review

State of the art: the treatment of systemic lupus erythematosus

Giulia Costanzo et al. Curr Opin Allergy Clin Immunol. .

Abstract

Purpose of review: Systemic lupus erythematosus (SLE) is a systemic autoimmune disease with dysregulated cells in the immune system. The disease affects organs like kidneys, nervous system, joints, and skin. To manage SLE effectively, novel treatments targeting immune system components have been developed. This review investigates the therapeutic potential of existing targeted therapies and explores future innovative approaches for well tolerated, personalized treatment.

Recent findings: SLE treatment involves cytokine targets and specific immunologic pathways, with even small molecules involved.

Summary: The advanced therapeutic options in SLE management give clinicians more tools to control disease activity according to personalized medicine.

PubMed Disclaimer

References

    1. Gergianaki I, Bortoluzzi A, Bertsias G. Update on the epidemiology, risk factors, and disease outcomes of systemic lupus erythematosus. Best Pract Res Clin Rheumatol 2018; 32:188–205.
    1. Ocampo-Piraquive V, Nieto-Aristizábal I, Cañas CA, et al. Mortality in systemic lupus erythematosus: causes, predictors and interventions. Expert Rev Clin Immunol 2018; 14:1043–1053.
    1. Aringer M. EULAR/ACR classification criteria for SLE. Semin Arthritis Rheum 2019; 49:S14–S17.
    1. Nashi RA, Shmerling RH. Antinuclear antibody testing for the diagnosis of systemic lupus erythematosus. Rheum Dis Clin North Am 2022; 48:569–578.
    1. Russell AS. The variability of antinuclear antibody testing. J Rheumatol 2021; 48:1190.2-1190.

MeSH terms